of sleep on gene expression in the brain are reviewed and the functional categories of waking-related and sleep-related transcripts are discussed.
Sleep phenotypes
Studies in the 1930s reported that some sleep phenotypes have higher concordance in monozygotic than in dizygotic twins, suggesting some genetic basis (reviewed in REF. 6 ). To study this phenomenon it is necessary to define and characterize the phenotypes of sleep: how much, how well and when we sleep (FIG. 1) . It is noteworthy that sleep phenotypes can change independently of each other. For instance, sleep can be poorly restorative and yet of normal duration. Similarly, in some circadian sleep disorders the preferred bedtime occurs too early or too late, but daily sleep amount and sleep quality are preserved.
Sleep is tightly regulated by two mechanisms that work partly independently of each other: the circadian and the homeostatic mechanisms (FIG. 1a) . The circadian mechanism reflects how sleep propensity changes over 24 h, and its function is to restrict sleep to a time of day that is ecologically appropriate. In mammals, the suprachiasmatic nucleus (SCN) of the hypothalamus is responsible for circadian rhythms. After SCN lesions sleep is no longer consolidated in one major phase (the day in rodents, the night in flies and humans), but occurs in short episodes throughout the 24 h period. The homeo static mechanism reflects how sleep pressure accumulates during wakefulness and is discharged during sleep. If waking is prolonged beyond its physiological duration (~16 h in humans) sleepiness increases and performance decreases, and when sleep is finally permitted its duration and/or intensity are greater than in baseline conditions. Sleep homeostasis is controlled
Slow waves
Oscillations of cortical origin that have frequencies in the delta band.
Rapid-eye-movement (REM) sleep
The second phase of sleep observed in mammals and birds. In REM sleep the muscle tone is reduced or absent, but the EEG is similar to waking. REM theta activity (4-7 Hz) is also present.
Spindles
Waxing and waning oscillations of thalamic origin, the frequency of which is in the sigma band.
Non-rapid eye movement (NREM) sleep
One of the two types of sleep observed in mammals and birds. NREM sleep includes slow-wave sleep, characterized mainly by large slow waves.
centrally by the interaction between sleep-promoting neuronal groups in the hypothalamus and basal forebrain and wake-promoting groups in the hypothalamus and brainstem. Sleep need is also regulated locally: brain regions that have undergone synaptic potentiation (for example, after learning) show larger slow waves, reflecting deeper sleep states 7 . Sleep quantity (that is, the duration of total sleep and of its various phases) and quality (including latency to sleep, the number of brief arousals after sleep onset and the number of large slow waves) also belong to the sleep phenotypes that have to be accounted for when sleep regulation and function are assessed (FIG. 1b) . Sleep quantity and quality in humans is assessed by measuring brain electrical activity with the electroencephalogram (eeg). eeg patterns change predictably depending on behavioural state, from the low-voltage, fast activity of waking and rapid eye movement (REM) sleep to the slow waves and spindles of non-rapid eye movement (NREM) sleep (FIG. 1b) . more refined information about sleep quality comes from the analysis of the eeg power spectrum, which measures the extent to which specific frequency bands are represented in the eeg signal (FIG. 1b) . Interestingly, recent studies found strong heritability of the sleep eeg power spectrum 8, 9 
.
evidence for the heritability of other sleep traits is listed in Supplementary information S1 (table) .
The most studied frequency band is the eeg delta activity -the eeg power in the 0.5-4.5 Hz range during NRem sleep, also called slow-wave activity (SwA). The greater the SwA, the deeper NRem sleep is and the more difficult it is to wake up when a stimulus is delivered 10 . moreover, the longer the duration of waking, the higher the level of SwA is at sleep onset 11 . Thus, delta activity is considered to be a marker of sleep intensity as well as of sleep need. Sleep in rodents, birds and other animals is also customarily quantified using eeg, whereas behavioural criteria are used as indicators of sleep in fish and invertebrates. It is worth pointing out that in almost all animals sleep is characterized by quiescence (marine mammals are an exception) and increased arousal threshold. The latter is the most important feature that distinguishes sleep from 'rest' or quiet waking, suggesting that the reduced ability to respond to the environment is a requirement for the restorative function of sleep, and can be captured without the eeg 12 . Thus, eeg is crucial for a detailed analysis of NRem and Rem sleep in many vertebrates, but our understanding of sleep regulation and functions can equally benefit from behavioural analysis, as done in several newly introduced invertebrate animal models (TABLE 1) .
Sleep studies across species Studies in flies, mice and humans have identified many genes that affect sleep. These genes can be grouped into four major functional categories (see Supplementary information S2 (table) ).
Studies in flies.
Studies over the past 8 years have demonstrated that the fruit fly shows most of the fundamental features of mammalian sleep (TABLE 1) . Flies are ideal for forward genetic approaches (BOX 1) because their genome is less redundant than that of the mouse or human, and thus a mutation in the fly is more likely to yield a strong phenotype. Recently, the naturally occurring variation in both sleep phenotypes and mRNA expression levels of wild-derived inbred lines has also been used as a promising approach to identify candidate genes 13 . Knowledge of the genetic basis of sleep will also benefit from studies in the zebrafish Danio rerio and the roundworm Caenorhabditis elegans (TABLE 1) , both of which have recently been shown to have a sleep-like state [14] [15] [16] [17] .
Studies in mice.
Almost all mouse genes known to affect sleep have been identified by reverse genetics studies. more than 70 mutant lines have been tested so far 2, 18 (see  Supplementary information S2 (table) ). QTL analysis (BOX 1) has succeeded twice in linking a single mouse gene to a specific frequency of the sleep eeg 19, 20 , whereas no mouse gene has been identified using mutagenesis screening so far. These studies suggest that, first, most mouse mutant lines show effects on at least one sleep phenotype, which is perhaps not surprising as these lines carry mutations in 'candidate' genes. Second, the effects on sleep quantity -if any -are usually small, with increases or, in most cases, decreases in total sleep of ~20% or less, due to a decline in NRem or Rem sleep. very few mutations affect both sleep phases, and then almost always in the same direction (prokineticin 2-deficient mice 21 and corticotropin-releasing hormoneoverexpressing mice 22 are exceptions; see Supplementary information S2 (table) ). Third, changes in the response to sleep deprivation, when present, are usually small, although caution is needed to interpret these results because most studies do not assess sleep homeostasis in a comprehensive manner.
Studies of sleep disorders in humans.
In several cases the genetic basis of human sleep disorders has been clarified, and the identified candidate genes have been tested in animal models. examples that are discussed here include
Box 1 | Methods to identify genes that affect sleep
Several strategies can be used to identify sleep-related genes. In reverse genetics a candidate gene is mutated, and then the effects of the mutation on sleep are assessed. Candidate genes are chosen based on their known function, which makes them likely to be relevant for sleep. In forward genetics the starting point is the phenotype, and a significant part of the work involves going back to the genotype to identify the responsible gene. This approach is unbiased and novel genes can be discovered. Forward genetic methods include quantitative trait loci (QTL) analysis and mutagenesis screening, which can complement each other. QTLs are stretches of genome that are closely linked to the genes that underlie the phenotype being studied. QTL analysis starts with the crossing of two inbred mouse strains that differ in the trait under investigation and then maps a chromosomal region that segregates with the phenotype in the progeny. The region may contain either a single major gene (that explains >25% of the genetic variance of a trait) or several genes with small effects. In mutagenesis screenings random small mutations are induced over the entire genome. Insertional mutagenesis uses transposable elements (in flies) to induce mutations, whereas chemical mutagenesis uses ethylmethane sulphonate (EMS) (in flies) or N-ethyl N-nitrosourea (ENU) (in mice). In these studies hundreds of mutated mice or thousands of mutated flies are screened for the phenotype of interest. Behavioural analysis is preferred because it is less time consuming and less expensive 120 . the hypocretin/orexin system and its role in narcolepsy, and Period (Per) genes, which when mutated result in abnormal circadian regulation.
Ion channels
Over the past 3 years, mutagenesis screenings have identified two fly genes with striking effects on fly sleep, namely Shaker and sleepless (also known as CG33472). The first gene, Shaker, which was identified with ethylmethane sulphonate mutagenesis
, codes for the α-subunit of a tetrameric potassium channel that mediates a voltage-activated fast-inactivating I A current 23 . Homologous channels in vertebrates have similar properties and, in both mammals and flies, I A has a major role in the control of membrane repolarization and transmitter release 23 . Flies carrying minisleep or other Shaker loss-of-function mutations sleep only 2-4 h every day rather than 8-10 h, but their circadian and homeostatic regulation of sleep are normal 24 . moreover, learning and memory in these flies is impaired, and lifespan is reduced, although it is unclear whether these deficits can be ascribed to reduced sleep 24, 25 . Hyperkinetic is a gene that codes for a regulatory β-subunit that interacts with the pore-forming α-subunits coded by Shaker. Hyperkinetic loss-of-function mutations also cause a short-sleeping phenotype, impairment in learning and memory, and reduced lifespan 25 . In Hyperkinetic mutants sleep is not reduced as much as in Shaker mutants, which is to be expected as in Hyperkinetic-null flies the I A current is reduced but not abolished.
sleepless was identified using insertional mutagenesis 26
. sleepless flies, like the most extreme Shaker-null mutants, sleep only ~2h a day (~85% less than controls), mainly owing to a decrease in sleep episode duration. sleepless codes for a glycosylphosphatidylinositolanchored protein with unknown function, and has no obvious vertebrate homologue. Quiver, however, a gene previously identified from a mutation that affects the I A current, is an allele of sleepless, and sleepless flies have reduced levels of Shaker. This suggests that the sleepless The waking 'activated' EEG is dominated by lowvoltage, fast activity in the beta (>13 Hz) and alpha (8-13 Hz) ranges. NREM sleep comprises a transitional stage 1 (N1, not shown), followed by stage 2 (N2) when alpha activity disappears, and then N3 or slowwave sleep (SWS), when the EEG shows prominent slow waves 119 . The higher the number of slow waves, the deeper the NREM sleep is -that is, the more difficult it is to wake up. Sleep spindles are waxing and waning oscillations of thalamic origin, the frequency of which is within the sigma band (12-16 Hz); slow waves are of cortical origin and have frequencies within the delta band, also called slowwave activity (SWA, <4.5 Hz). S, sleep; W, waking.
short-sleeping phenotype is at least in part mediated by the Shaker current. Nevertheless, there are some interesting differences between Shaker and sleepless flies, most notably that only the latter show a reduced homeostatic response, as indicated by the absence of changes in sleep duration after sleep deprivation.
why do mutations affecting the I A current decrease sleep duration so significantly? In mammals, neurons in the cortex and thalamus are more hyperpolarized in sleep than in waking 27 , and one possibility is that these mutations impinge on the core cellular mechanisms of sleep by changing overall neuronal excitability (FIG. 2) . Based on sequence similarity, the closest mammalian homologues of the Shaker gene are the α-subunits of the Kv1 family of potassium channels; the Kv2, Kv3 and Kv4 families are more distantly related ('Shaker-like'). Kv1 channels activate in the subthreshold voltage range in many neurons and can act as extremely diverse regulators of neuronal excitability 28 (FIG. 2) . mice lacking the closest mammalian homologue of Shaker, Kv1.2 (also known as Kcna2), sleep less. Their short-sleeping phenotype, however, is far from being as dramatic as in Shaker flies 29 , perhaps because of redundancy -there is one Shaker gene in Drosophila melanogaster, but at least 16 genes code for α-subunits of voltage-dependent potassium channels in mammals 30, 31 . A striking sleep phenotype is observed in double knockout (KO) mice lacking the voltage-dependent potassium channels Kv3.1 (also known as KCNC1) and Kv3.3 (also known as KCNC3) 32 , which sleep ~40% less than wild-type mice, have shorter sleep episodes, exhibit an overall decrease in the eeg power spectrum that is more evident in NRem sleep than in Rem sleep or waking, and exhibit no response to sleep deprivation. These mice are also hyperactive and show motor dysfunction, which might be partly responsible for their sleep fragmentation 32, 33 . The mechanisms underlying the effect of these mutations on sleep is probably different from those involved in Shaker and sleepless mutants because Kv3-type channels are mainly expressed in cortical and thalamic gABA (γ-aminobutyric acid)-expressing interneurons, in which they enable repetitive high-frequency firing 34 . whether human extreme short sleepers have mutations in voltage-dependent potassium channels remains unknown, but in one case of morvan's syndrome, a rare autoimmune disorder with central symptoms, marked sleeplessness has been associated with the presence of autoantibodies against voltage-dependent potassium channels 35 . Another candidate sleep gene that was identified in mice is Cav3.1 (also known as Cacna1g), which codes for the α1g subunit of the T-type calcium channels. These channels have a crucial role in the regulation of most of the neuronal oscillations displayed by thalamic and cortical neurons during NRem sleep 36 . Two independent studies have reported a decrease of ~20% in NRem sleep and more frequent brief awakenings, which are a sign of disrupted sleep, in mice lacking Cav3.1 either globally or in most of the thalamus, whereas cortical deletion had no effect 37, 38 . Detailed experiments to assess the effects of these mutations on the sleep eeg still need to be carried out.
Circadian regulation
At the molecular level, circadian genes interact and determine circadian rhythmicity. most of these genes have been tested for their effects on sleep (see Supplementary information S2 (table) ). Double KO mice of the circadian genes Cryptochrome 1 and Cryptochrome 2 sleep more and have higher NRem delta activity, but show little further increase in sleep duration and intensity after sleep deprivation 39 . Other mutations of circadian mouse genes (Clock, Arntl, neuronal Per-ARNT-Sim (PAS) domain protein 2 and prokineticin 2) also result in an abnormal response to sleep deprivation, as do mutations of the fly circadian genes cycle and Clock (TABLE 1) . Overall, it seems that circadian mutations affect not only the timing of sleep, as expected, but also its homeostatic regulation.
Per genes. A functional circadian clock seems to require oscillations of PeR protein levels and its phosphorylation and/or its rhythmic nuclear localization (FIG. 3) . Flies have only one Per gene. Flies lacking Per have a disrupted rest-activity cycle and reduced sleep, but whether the short-sleeping phenotype is due to the specific loss of Per remains unclear 40 . Loss of Per2 in mice (mammals have three Per genes) also disrupts locomotor activity rhythms; moreover, cortical Per2 expression levels change depending on both the time of day (they are high at night) and the behavioural state (they are high in waking) 39, [41] [42] [43] . As Per2 induction is sensitive to the NAD/NADH ratio 44, 45 it might reflect the level of brain activity 46 , which varies with sleep and waking. Thus, Per2 could be an essential part of the central clock, as well as of the mechanism that regulates sleep need based on waking duration (FIG. 3) Two recent reports found strong heritability of the sleep EEG power spectrum 8, 9 , extending previous results in normal sleepers (not twins), which showed that the sleep EEG is very consistent across nights in the same subject but varies considerably from one individual to another. Other studies found that the trait-like nature of the human sleep EEG is evident at most frequencies below 15-16 Hz [121] [122] [123] [124] [125] [126] . Heritability is probably not as strong for delta activity, which is significantly affected by sleep-waking history. It is worth mentioning that the spectral composition of the human EEG shows striking heritability also during waking, with estimates ranging from 70 to 90% for most frequency bands 127, 128 . The coherence of the waking EEG is also under strong genetic influence 129, 130 . In fact, the EEG is among the most hereditable traits in humans, although few specific genes have been identified so far. A linkage disequilibrium between the beta frequency of the human EEG and a GABA A (γ-aminobutyric acid A) receptor locus has been reported in a rest state with eyes closed, but it is unknown whether this finding is specific for relaxed waking or extends to the sleep state 131 . Thus, the challenge for the future will be not only to identify which specific genes influence the human EEG, but also to determine to what extent their effects are unique to sleep or waking. It is likely that at least some of the inter-individual differences in the human EEG are related to genetic factors that are independent of behavioural state. 
Behavioural definition of sleep
Quiescence and increased arousal threshold 88, 132 Quiescence and increased arousal threshold [14] [15] [16] Quiescence and increased arousal threshold during development (lethargus) 17 ; preliminary evidence for quiescence and increased rest after deprivation in adults 133 
Documented changes in brain activity
Electrical activity in the brain is reliably correlated with behavioural state 134 No data available
No data available
Homeostatic regulation of sleep
Increase in sleep time, arousal threshold and duration of sleep episodes and decrease in brief awakenings after sleep deprivation; homeostatic regulation is largely independent of the circadian clock 88, 132, 135 , 88 Sleep occurs mainly at night [14] [15] [16] Lethargus is time locked to the expression of lin-42, the C. elegans orthologue of the circadian gene Period
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Gene expression during sleep and waking
Similar changes to those seen in mammals 79, 84 No • Dopamine: a DAT mutation decreases daily sleep amount by ~60%, consistent with reduced NREM sleep in DATKO mice 141, 142 • GABA: genetic manipulations that decrease GABA transmission result in reduced sleep 143 • cAMPdependent PKA-CREB activity: inverse relationship with daily sleep amount in flies and mice 98, 144 • EGFR signalling: affects the circadian regulation of sleep but not sleep amount in mammals [148] [149] [150] ; in flies, genetic manipulations of the EGFR pathway affect sleep amount without affecting its circadian regulation 151 • Serotonin: complex role in mammals, where it may increase/decrease sleep depending on time of day 152 ; sleeppromoting role in flies 153 • Increased sleep with melatonin, GABAergic hypnotics, α2adrenergic agonists and histaminergic H1 antagonists 14, 145, 146 • Unclear whether the hypocretin/orexin system is wakepromoting as in mammals 15 or sleeppromoting 16 • sleep (SwS) and higher NRem delta activity, the latter also after sleep deprivation 47 . PER3 5/5 subjects also show higher alpha and theta eeg activity during waking and Rem sleep (both signs of increased sleep pressure), and after total sleep deprivation (but not chronic sleep restriction 48 ) they are more impaired in executive functioning tasks in the early morning than PER3 4/4 carriers 47, 49 . Significant inter-individual differences in the cognitive impairment caused by sleep loss have been found before (reviewed in REF. 50 ). Recent experiments suggest that these individual differences are also associated with different patterns of neural activation, as measured using functional mRI 51 . Further studies are required to confirm that PER3 has a crucial role in modulating susceptibility to sleep deprivation.
The human familial advanced sleep phase syndrome (FASPS) is transmitted in a highly penetrant autosomal dominant manner. FASPS subjects have a normal duration of sleep but go to sleep ~4 h earlier than usual (extreme early birds). Some FASPS individuals carry a serine to glycine mutation in PER2, and in vitro the mutation affects the ability of casein kinase Iε to phosphorylate PeR2 (REF. 52 ). The same mutation in mice phenocopies human FASPS 53 . A missense mutation in the human casein kinase Iδ gene (CSNK1D) also results in FASPS and reduces the kinase's activity in vitro 54 . These and other studies showed that the extent to which Per proteins are phosphorylated greatly affects their nuclear accumulation and influences the endogenous circadian period, suggesting that future proteomic studies could shed further light on how sleep and circadian rhythms are regulated. genetic-association studies have also suggested a link between delayed sleep phase syndrome (DSPS, which results in extreme night owls) and several genes, including PER3 (see REF. 55 for a review).
Neurotransmission
In general, genetic studies have largely confirmed the arousal-promoting role of the noradrenergic, histaminergic, serotonergic, cholinergic and hypocretin/orexin systems (see Supplementary information S2 (table)). more specific roles for some of these systems in regulating certain sleep phenotypes have been reported. For example, hypocretins/orexins have been shown to be essential for stabilizing sleep and wakefulness 56 . Indeed, narcolepsy, a neurological disorder caused by hypocretin/orexin deficiency, is characterized by the inability to maintain long waking periods, abrupt transitions into NRem sleep and abnormal intrusions of Rem sleep into waking 56 . Canine narcolepsy is an autosomal recessive fully penetrant disorder resulting from a mutation in the gene coding for hypocretin receptor 2 (REF. 4 ). In mice, a narcolepsy-like phenotype is present in the orexin (also known as Hcrt)-KO mice, in which the hypocretin/ orexin-producing cells are spared but the corresponding peptides are lost. A narcolepsy-like phenotype is also found in the hypocretin/orexin-ataxin 3 transgenic rats and mice, in which both the cells and the peptides are missing.
genetic studies have also shown that the noradrenergic and histaminergic systems are important in maintaining arousal, as mice deficient in histamine (Hdc-KO mice) or noradrenaline/adrenaline (Dbh-KO mice) tend to sleep more and have less trouble going back to sleep after exposure to mild stress. On the other hand, mice lacking the serotonin transporter SeRT or serotonin receptor 1A have 40-50% more Rem sleep, in line with the observation of a role for serotonin in the regulation of this behavioural state.
Reverse genetics has also clarified the mechanisms by which some drugs affect sleep. For instance, Figure 2 | Proposed mechanism for the short-sleeping phenotype caused by loss-of-function mutations of Shaker-encoded potassium channels. Normally, the opening of Shakerencoded channels allows potassium ions to exit the neuron, bringing the membrane potential to more hyperpolarized (more negative) levels, close to the resting membrane potential. Mutations that reduce the total number of these channels and/or decrease the time the channels remain open tend to bring the membrane potential to more depolarized (more positive) levels, closer to the threshold for firing an action potential (blue line in graph). Nature Reviews | Neuroscience adenosine-mediated neurotransmission, which is blocked by caffeine, plays an important part in the homeostatic regulation of sleep, and adenosine levels increase during waking and decrease during sleep in the cortex and basal forebrain of rats and cats (reviewed in REF. 57 ). mice lacking the adenosine receptor A2AR are insensitive to the wake-promoting effects of caffeine, consistent with the fact that in humans a polymorphism in A2AR (also known as ADORA2A) contributes to individual sensitivity in the effects of caffeine on sleep 57 . In humans, a functional polymorphism in the gene coding for the catabolic enzyme adenosine deaminase (ADA) results in a ~20-30% decrease in enzymatic activity in blood cells, ~50% increase in SwS duration and ~60% increase in NRem delta activity, with no change in total sleep time 58 .
Other signalling pathways and hormones various molecules have been tested for their effects on sleep, but no systematic analysis of all major signalling pathways has been attempted so far. Although it is not possible to provide a comprehensive summary of these studies here (see Supplementary information S2 (table)), it is clear that a few mutations produce large (40-50%) changes in sleep quantity. They include those affecting RIm1α, a protein involved in synaptic vesicle release 59 , and uBe3A, a ubiquitin protein ligase, which when deleted causes abnormal eeg discharges 60 .
During Rem sleep the eeg shows prominent theta activity, which varies greatly in frequency among inbred mouse strains (slow and fast theta strains). By using QTL analysis followed by fine mapping, one study was able to link Acads to theta frequency 19 . Acads encodes the short-chain acyl-coenzyme A dehydrogenase that is involved in fatty acid β-oxidation, but the mechanism by which its deficiency can slow down the peak theta frequency (from ~8 Hz to 6 Hz) remains unclear 19 . Another study that used forward molecular and reverse genetic approaches showed that Rarb, the gene encoding retinoic acid receptor-β, is important for determining the contribution of delta activity to the eeg during NRem sleep 20 . The mechanism by which this nuclear receptor affects the amount of delta activity, and thus cortical synchrony during sleep, is unclear, but it may depend on its role in development, neural plasticity and dopamine neurotransmission. Rarb does not seem to have a role in sleep homeostasis.
The Dps1 locus. A recent study using 25 recombinant inbred mouse strains found that the increase in NRem delta activity after sleep deprivation depends on both duration of sleep and genotype. It was found that Dps1, a QTL locus on mouse chromosome 13 that contains more than 200 genes, accounts for 49% of the genetic variance in this trait 61, 62 . Two follow-up studies identified Homer1a, an immediate early gene induced by neuronal activity 63, 64 , as a probable candidate gene within Dps1 (REFS 65, 66) . The conclusion was based on the consistent and strong induction of Homer1a after sleep deprivation in the whole brain of several mouse strains 65 , the higher expression of cortical Homer1a in the strain with the greatest increase in delta activity, and the presence of single nucleotide polymorphisms in an upstream regulatory region of the gene 66 . It remains to be proven conclusively whether Homer1a has a role in sleep homeostasis. Future studies might show that Homer1a-KO mice have a significantly impaired response to sleep deprivation. As Dps1 contains numerous genes, it is also possible that other major candidates will be identified within this locus. Flies lacking the single D. melanogaster Homer gene are hyperactive and show defects in courtship behaviour, but whether their sleep is affected is unknown 67 .
Studies in humans: genetic control of sleep disorders Fatal familial insomnia (FFI)
. FFI is a rare autosomal dominant disease resulting from a point mutation at codon 178 of PRNP. The same mutation is also present in patients affected by the familial form of CreutzfeldtJakob disease (CJD), another prion disease with extensive cortical, rather than thalamic, degeneration and in which dementia, rather than insomnia, is the main clinical feature. In patients with FFI, codon 129 on the mutated allele codes for methionine, whereas in patients with CJD it codes for valine (reviewed in REFS 68, 69) . FFI is characterized by a decrease in sleep spindles, sleep fragmentation, a reduction in total sleep time, loss of the circadian regulation of sleep, disappearance of SwS and intrusion of a Rem-like state into wakefulness. FFI patients show accumulation of abnormal PRNP in the brain, but PRNP levels correlate neither with the severity of the disease Period (Per) mRNA levels grow during the day, whereas the protein levels peak at night, when Per enters the nucleus and blocks its own expression. These circadian changes are similar regardless of whether the animal is diurnal (like flies, which sleep mainly at night) or nocturnal (like rats, which sleep mainly during the day). Rodents forced to stay awake during the day show increased Per mRNA levels in the cerebral cortex. However, in both flies and mammals sleep deprivation (SD) does not usually reset the circadian clock -that is, SD does not cause phase shifts. S, sleep; W, waking.
Sleep consolidation
Consolidated sleep is characterized by long sleep episodes, little waking after sleep onset (WASO) and only few brief awakenings.
nor with the extent of neuronal degeneration. It is also unclear to what extent the sleep disturbances contribute to the death of FFI patients. mice lacking PRNP have fragmented sleep, suggesting that the normal protein might promote sleep consolidation 2, 3 . Sleep problems also exist in patients with CJD, and transgenic mice carrying the mouse homologue of the human mutation show a large decrease in Rem sleep and periods of a 'mixed' state that cannot be easily classified as either sleep or waking 70 . Narcolepsy. In dogs and mice narcolepsy is genetically determined, but in human narcolepsy non-genetic factors have a major role, as suggested by its low (~30%) concordance in monozygotic twins. No association has been found between human narcolepsy and polymorphisms in the genes of the hypocretin/orexin system, and so far only one case of narcolepsy with an unusually early onset has been associated with a mutation in the gene that encodes preprohypocretin 71 . However, most patients with narcolepsy-cataplexy have low or undetectable levels of hypocretins, and narcolepsy is strongly associated with human leucocyte antigen (HLA) alleles, in particular HLA DQB1*0602. This suggests that the deficit in hypocretin-mediated neurotransmission in human narcolepsy could be due to an autoimmune attack 72 . Consistent with this, a recent genome-wide association study found that narcolepsy is associated with the T cell receptor α-locus 73 .
Restless leg syndrome (RLS).
RLS is a common sleep disorder that is often characterized by periodic limb movements during sleep. RLS can be familial (autosomal dominant in up to a third of cases). Although dopaminergic agonists are used to treat primary RLS, no association has been found between this disorder and genes involved in dopamine-mediated neurotransmission. Instead, recent genome-wide case-control studies identified four predisposing loci on chromosomes 2p, 6p, 9p and 15q. One locus is within the homeobox gene MEIS1, which is involved in limb development. The second is within BTBD9, which might have a role in iron storage. The third was found between the gene coding for mitogen-activated protein kinase kinase 5 and LBXCOR1, which encodes a homeodomain transcription factor that is important for the development of gABA-expressing interneurons in the dorsal horn of the spinal cord. The fourth was identified within the gene that encodes protein tyrosine phosphatase receptor type δ 74, 75 . A second genome-wide association study also found an association between BTBD9 and RLS with periodic limb movements 76 . Together, the four loci might explain more than 50% of the risk for RLS in individuals with european ancestry.
Obstructive sleep apnea syndrome (OSAS). OSAS, a common disorder characterized by recurrent episodes of apnea/hypopnea (no or reduced airflow) during sleep, is also to some extent under genetic control. The genetic basis of this disorder, however, is difficult to study, because many of the risks factors for OSAS, including obesity and alterations of the craniofacial morphology, are also under genetic control 77 .
effects of sleep and waking on brain genes It is well established that the patterns of neural activity, neurotransmitter and neuromodulator content, brain metabolism and the ability to react to external stimuli differ between sleeping and awake animals. Recent whole-genome transcriptomic studies have revealed that the brains of sleeping and awake animals also differ at the molecular level. In rats, mice, flies and sparrows hundreds of brain transcripts change their level of expression between sleep and wakefulness 41, 65, [78] [79] [80] [81] [82] [83] [84] [85] [86] . In rats and mice, these changes occur mainly in the cerebral cortex, cerebellum and hypothalamus, but also in other brain areas. For instance, in one study up to ~5% (752 of 15,459) of the transcripts tested in the cerebral cortex was up-or downregulated in rats that had slept for 8 h relative to rats that had been spontaneously awake or sleep deprived for 8 h 41 . A similar number of cortical transcripts changed their expression in correlation with the time of day, independent of behavioural state, suggesting that day-night time and sleep-wakefulness influence cortical gene expression to a similar extent 41 . In general, across studies, there are as many 'sleep' transcripts (with higher expression during sleep than waking) as there are 'waking' transcripts. This result suggests that, despite being usually associated with behavioural inactivity, sleep is far from being a quiet state at the cellular level. most importantly, sleep-related and wakefulness-related transcripts belong to different functional categories, suggesting that the two behavioural states may favour different cellular processes 41 . moreover, several of the molecular correlates of sleep and wakefulness first identified in rats and mice have subsequently been found in fruit flies and sparrows (FIG. 4) . The overlap in some major gene categories is remarkable considering that these studies differ not only with respect to the animal species that was tested, but also in terms of design (for example, using sleep-deprived as opposed to spontaneously awake animals), duration of wakefulness (3-8 h), brain region and statistical approach.
Waking-related transcripts. Three functional categories of transcripts are most consistently increased during waking and short-term sleep deprivation relative to sleep (FIG. 4) . The first group comprises genes involved in energy metabolism, including those coding for mitochondrial proteins, glucose transporters and proteins related to glycogen metabolism [86] [87] [88] [89] . Their upregulation might represent a mechanism by which the brain responds to the high energy requirements of wakefulness. This response, however, does not seem to persist when sleep deprivation is prolonged for more than a few hours 80, 90 . Imaging studies in animals 91 , healthy human subjects 92 , and patients with FFI 93 also show either no change or a decrease in cerebral metabolic rate after prolonged sleep loss.
The second group of waking-related transcripts codes for proteins involved in the response to cellular stress, including heat shock proteins and chaperones 41, 78, 79, 82, 83, 85, 86 . This suggests that the absence of sleep could be a stress for brain cells. In support of this hypothesis, in the mouse cerebral cortex a few hours of sleep deprivation induce Nature Reviews | Neuroscience the 'unfolded protein response' , a global stress response that involves the induction of the chaperone BiP in the endoplasmic reticulum, which promotes the degradation of misfolded proteins, and a decrease in protein synthesis 94 . Importantly, there are no major signs of brain cellular damage after prolonged waking 95, 96 , an indication that the stress response must be protective. This is consistent with the observation that mutant flies unable to mount a strong stress response during sleep deprivation die of sleep loss earlier than controls 97 .
The third group of wakefulness-related transcripts has a role in synaptic plasticity, and more specifically in synaptic potentiation 41, 65, 79, 86, 98 . Overall, the induction of these genes suggests that synaptic potentiation is favoured during wakefulness relative to sleep. Consistent with this, recent experiments in flies and rats showed that molecular and electrophysiological markers of net synaptic potentiation prevailed in waking, whereas markers of net synaptic depression prevailed in sleep [99] [100] [101] .
Sleep-related transcripts. Some of the transcripts with increased expression during sleep are involved in protein synthesis 41, [84] [85] [86] (FIG. 4) . These findings are in agreement with studies that identified a positive correlation between sleep and protein synthesis [102] [103] [104] [105] [106] [107] . whether sleep favours protein synthesis globally, or enhances the synthesis of specific classes of proteins, is still unclear.
Another group of sleep-related transcripts includes CamkIV (calmodulin-dependent protein kinase 4), a gene that has recently been found to be involved in synaptic scaling 108 , and other genes that have been associated with synaptic depression and depotentiation, such those coding for calcineurin, FK506 binding protein 12, inositol-1,4,5-trisphosphate receptor and amphiphysin II 41 . Thus, although wakefulness is the appropriate time for memory acquisition and synaptic potentiation, sleep might favour complementary aspects of plasticity, such as synaptic consolidation or downscaling. An involvement of sleep in such processes is suggested by behavioural and physiological experiments showing that sleep improves the performance of different learning tasks 109, 110 . At this stage, however, the mechanism by which sleep enhances performance is still debated. One idea is that sleep consolidates synapses activated by learning during the previous waking period, perhaps through mechanisms that require cortical spindle activity and the slow waves of NRem sleep 111, 112 . Another possibility is that, as wakefulness is associated with a diffuse potentiation of synaptic circuits, resulting in a net increase in synaptic weight, sleep produces a generalized depression of synapses. This downscaling would benefit the brain because it decreases the energetic cost of synaptic activity, eliminates weak and ineffective synapses, reduces cellular stress and increases signal-to-noise ratios 113 . Finally, a large group of sleep-related transcripts is involved in membrane trafficking and maintenance 41, [84] [85] [86] . Some of these transcripts are involved in exocytosis and neurotransmitter release, others in synaptic vesicle recycling, tethering and docking of vesicles to their target organelles, and cycling between trans-golgi network and plasma membrane. Other transcripts are important for the synthesis and maintenance of membranes in general and of myelin in particular, including genes expressed in oligodendrocytes coding for myelin structural proteins, myelin-related receptors and enzymes. Also, transcripts with higher expression in sleep code for enzymes involved in the synthesis and transport of cholesterol, a major constituent of myelin and other membranes and an important factor in regulating synaptic efficacy 114, 115 . Depletion of cholesterol or sphingolipids leads to instability of surface During sleep, the expression of proteins involved in protein synthesis, synaptic depression and lipid metabolism is increased, whereas during waking the expression of proteins implicated in energy metabolism, synaptic potentiation and stress responses increases (see Supplementary information S2 (table) for more detailed information). Conservation of changes across flies (F), mice or rats (M), Djungarian hamsters (H) and sparrows (S) is indicated. Data from REFS 41, 78, 87 . AMPA, αamino3hydroxy 5methyl4isoxazole propionic acid; BDNF, brainderived neurotrophic factor; BiP, immunoglobulinheavychainbinding protein; CAMKIV, calmodulindependent protein kinase 4; EF2, elongation factor 2; IF4AII, initiation factor 4AII; LTD, longterm depression; LTP, longterm potentiation; NARP, neuronal activityregulated protein; PCREB, phosphorylated cAMP response elementbinding protein.
AmPA (α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptors and gradual loss of synapses and dendritic spines 116 . Thus, it might not be by chance that sleep seems to be linked to membrane trafficking and cholesterol synthesis on the one hand, and to protein synthesis and synaptic homeostasis on the other hand.
Future directions
There is little doubt that more genes affecting sleep phenotypes will be identified in the near future, and it is reasonable to assume that most mutations will have less striking effects on sleep in mammals than in simpler organisms, as mammalian genomes are redundant. even in simpler organisms, however, we should not expect single genes to completely abolish sleep or its regulation, because sleep is a complex and highly regulated behaviour that is present in all the animal species that have been studied so far. This suggests that sleep has one or more fundamental functions, such as maintaining brain plasticity and saving energy 12 . A similar argument applies to the brain regions that are involved in initiating and maintaining sleep and waking: there are several sleep-promoting and arousal-promoting neural systems, and the lesion of one or even a few of them does not result in the complete and permanent lack of either sleep or waking.
Sleep genetic studies are bound to contribute further to our understanding of sleep regulation and function but are also challenging. The identification of the mutated gene in animal models or human disorders is becoming faster and cheaper. One major challenge lies in the choice of phenotype: which sleep parameters should we measure when searching for 'insomnia genes'? Another issue is the large number of subjects that are required for genome-wide association studies, which might be a limiting factor unless extensive collaborations across sleep centres around the world are initiated. Finally, large-scale mutagenesis screening remains time consuming and costly in mice, until -like with flies -automatic, highthroughput and yet sensitive methods to assess sleep in hundreds of animals at a time become available.
Nevertheless, as reviewed here, some genes with profound effects on sleep have already been identified in mammals, and others will follow. Neurons are more hyperpolarized during sleep than during waking, and mutations that can significantly change the resting membrane potential, the balance between inhibitory and excitatory neurotransmission, and/or the overall neuronal excitability of large sets of neurons are likely to affect the quantity and quality of sleep (as Shaker, sleepless and Kv3.1 or Kv3.3 mutants suggest). Also, in flies as well as in mammals, sleep homeostasis reflects not only the duration of prior waking, but also its intensity, and sleep need increases when waking is associated with learning 7, 117, 118 . Thus, it is probable that mutations in many plasticity-related genes will affect the homeostatic regulation of sleep. Overall, the identification of mutations that change the need for sleep, or make subjects resistant to the negative effects of sleep deprivation, could prove crucial to furthering our understanding of the functions of sleep.
